Overexpression of HIF-2α, TWIST, and CXCR4 Is Associated with Lymph Node Metastasis in Papillary Thyroid Carcinoma
Authors:
Open Access
- 29 October 2013
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2013, 1-9
Abstract
This study aimed to examine HIF-2α, TWIST, and CXCR4 expression in papillary thyroid carcinoma (PTC) and assesses the association of their expression with clinicopathological indicators. HIF-2α, TWIST, and CXCR4 protein expression in 129 PTCs, 61 nodular hyperplasia, and 118 normal thyroid tissue specimens was analyzed using immunohistochemistry. The protein expression levels of these three molecules were upregulated in PTCs. High protein expression of HIF-2α, TWIST, and CXCR4 was significantly correlated with lymph node metastasis (LNM) (). Furthermore, HIF-2α, TWIST, and CXCR4 protein expression was correlated with one another. Concomitant high expression of these molecules had stronger correlation with LNM than did each alone (for HIF-2α/TWIST,for HIF-2α/CXCR4,for TWIST/CXCR4, andfor HIF-2α/TWIST/CXCR4). Additionally, HIF-2α, TWIST, and CXCR4 mRNA expression were assessed in 30 PTCs, 10 nodular hyperplasia, and 10 normal thyroid tissue specimens using real-time RT-PCR. TWIST and CXCR4 mRNA expression levels were up-regulated in PTCs, and high mRNA expression of TWIST and CXCR4 was significantly correlated with LNM (and, resp.). These results demonstrated that the evaluation of HIF-2α, TWIST, and CXCR4 expression in PTC may be useful in predicting the risk of LNM.
Keywords
Funding Information
- Chongqing Natural Science Foundation of China (2011BA5038, 81072183, XBZD201002)
- National Natural Science Foundation of China (2011BA5038, 81072183, XBZD201002)
- Scientific Research Foundation for the Returned Overseas Chinese Scholars (2011BA5038, 81072183, XBZD201002)
- Scientific Research Foundation of Chongqing Medical University (2011BA5038, 81072183, XBZD201002)
This publication has 25 references indexed in Scilit:
- Synergistic Antitumor Effects of Endostar in Combination with Oxaliplatin via Inhibition of HIF and CXCR4 in the Colorectal Cell Line SW1116PLOS ONE, 2012
- Hypoxia inducible factor-2α: a critical mediator of aggressive tumor phenotypesCurrent Opinion in Genetics & Development, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancerCancer Science, 2008
- The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2αOncogene, 2007
- Hypoxia-inducible factors: central regulators of the tumor phenotypeCurrent Opinion in Genetics & Development, 2007
- Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long‐term Outcome in 2444 Consecutively Treated PatientsWorld Journal of Surgery, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survivalBritish Journal of Cancer, 2001